|
MBNL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69939617933323E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.1904000248656E-09 |
| Normal-vs-Stage2 |
2.09979999998833E-06 |
| Normal-vs-Stage3 |
1.48629997198668E-10 |
| Normal-vs-Stage4 |
1.00329999974669E-07 |
| Stage1-vs-Stage2 |
6.190800E-01 |
| Stage1-vs-Stage3 |
1.125600E-01 |
| Stage1-vs-Stage4 |
2.993600E-01 |
| Stage2-vs-Stage3 |
5.115800E-01 |
| Stage2-vs-Stage4 |
6.545400E-01 |
| Stage3-vs-Stage4 |
8.757200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.31049998314859E-10 |
| Normal-vs-AfricanAmerican |
6.795400E-04 |
| Normal-vs-Asian |
3.51100004625238E-09 |
| Caucasian-vs-AfricanAmerican |
7.344800E-01 |
| Caucasian-vs-Asian |
6.968500E-02 |
| AfricanAmerican-vs-Asian |
1.261160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80000003791037E-09 |
| Normal-vs-Female |
1.0189999954946E-09 |
| Male-vs-Female |
6.803600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04439999981665E-07 |
| Normal-vs-Age(41-60Yrs) |
9.55200363250697E-11 |
| Normal-vs-Age(61-80Yrs) |
4.53860005134032E-09 |
| Normal-vs-Age(81-100Yrs) |
1.423930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.648560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.563600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.302800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.737200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.321600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.412000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.593830E-01 |
| Classical-VS-Follicular |
8.219600E-01 |
| Classical-VS-Other |
1.257750E-01 |
| Classical-VS-Normal |
2.49609999336542E-10 |
| Tall-VS-Follicular |
2.446600E-01 |
| Tall-VS-Other |
3.521000E-01 |
| Tall-VS-Normal |
7.34230000132285E-08 |
| Follicular-VS-Other |
6.225700E-02 |
| Follicular-VS-Normal |
1.9398999999698E-06 |
| Other-VS-Normal |
6.808800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.43278788412272E-12 |
| Normal-vs-N1 |
3.81720000053321E-08 |
| N0-vs-N1 |
4.826600E-01 |
|
|
